Amitriptyline and Sertraline Interaction

Drug interaction information between Amitriptyline and Sertraline.

Amitriptyline and Sertraline have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Amitriptyline and Sertraline. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Amitriptyline

Tricyclic Antidepressant (TCA)

Drug B

Sertraline

Selective Serotonin Reuptake Inhibitor (SSRI)

How They Interact

Sertraline slows down the liver's ability to process amitriptyline. This can cause amitriptyline to build up to higher levels in your body.

FDA Label Information

While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.

Frequently Asked Questions

What SPL severity band is on file for Amitriptyline + Sertraline?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Sertraline has 34 labeled pairs on file vs Amitriptyline's 21. In the minor band specifically: Amitriptyline has 20 (also Fluoxetine, Paroxetine, Disulfiram, Flecainide); Sertraline has 31 (also Fluoxetine, Citalopram, Paroxetine, Atenolol).

What mechanism field is on file for Amitriptyline and Sertraline?

Sertraline slows down the liver's ability to process amitriptyline. This can cause amitriptyline to build up to higher levels in your body.

Sertraline's labeled portfolio outnumbers Amitriptyline

SPL source-record counts only. This page's band is minor · classes on file: Amitriptyline (Tricyclic Antidepressant (TCA)); Sertraline (Selective Serotonin Reuptake Inhibitor (SSRI)).

Amitriptyline

1 major · 0 moderate · 20 minor · 21 total

Sertraline

1 major · 2 moderate · 31 minor · 34 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.